| Authors: |
Franklin M; Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK., Fotheringham J; Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK., Taylor RS; School of Health and Well Being, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Powell PA; Sheffield Centre for Health and Related Research (SCHARR), Division of Population Health, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK., Retat L; AstraZeneca, Avinguda de Roma, 81 Eixample, 08029, Barcelona, Spain., Chen J; AstraZeneca R&D Pharmaceuticals, One Medimmune Way, Gaithersburg, MD, 20878, USA., Sanchez JJG; AstraZeneca, Avinguda de Roma, 81 Eixample, 08029, Barcelona, Spain., Gamble A; Health Economics & Outcomes Research Ltd, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., Carter P; Health Economics & Outcomes Research Ltd, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK. patrice.carter@heor.co.uk. |